312 related articles for article (PubMed ID: 33979132)
21. Arene Ruthenium(II) Complexes Bearing the κ-
Arlt S; Petković V; Ludwig G; Eichhorn T; Lang H; Rüffer T; Mijatović S; Maksimović-Ivanić D; Kaluđerović GN
Molecules; 2021 Mar; 26(7):. PubMed ID: 33806101
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, Structure and Cytotoxicity of N,N and N,O-Coordinated Ru
Mukherjee A; Koley TS; Chakraborty A; Purkait K; Mukherjee A
Chem Asian J; 2021 Nov; 16(22):3729-3742. PubMed ID: 34549886
[TBL] [Abstract][Full Text] [Related]
23. Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.
Dubarle-Offner J; Clavel CM; Gontard G; Dyson PJ; Amouri H
Chemistry; 2014 May; 20(19):5795-801. PubMed ID: 24668791
[TBL] [Abstract][Full Text] [Related]
24. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
Bugarcic T; Habtemariam A; Deeth RJ; Fabbiani FP; Parsons S; Sadler PJ
Inorg Chem; 2009 Oct; 48(19):9444-53. PubMed ID: 19780621
[TBL] [Abstract][Full Text] [Related]
25. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
[TBL] [Abstract][Full Text] [Related]
26. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
[TBL] [Abstract][Full Text] [Related]
27. Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.
Ludwig G; Kaluđerović GN; Rüffer T; Bette M; Korb M; Block M; Paschke R; Lang H; Steinborn D
Dalton Trans; 2013 Mar; 42(11):3771-4. PubMed ID: 23340605
[TBL] [Abstract][Full Text] [Related]
28. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
Pelletier F; Comte V; Massard A; Wenzel M; Toulot S; Richard P; Picquet M; Le Gendre P; Zava O; Edafe F; Casini A; Dyson PJ
J Med Chem; 2010 Oct; 53(19):6923-33. PubMed ID: 20822096
[TBL] [Abstract][Full Text] [Related]
29. New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action.
Pavlović M; Nikolić S; Gligorijević N; Dojčinović B; Aranđelović S; Grgurić-Šipka S; Radulović S
J Biol Inorg Chem; 2019 Mar; 24(2):297-310. PubMed ID: 30762123
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, characterization, antimicrobial and cytotoxic activity of novel half-sandwich Ru(II) arene complexes with benzoylthiourea derivatives.
Obradović D; Nikolić S; Milenković I; Milenković M; Jovanović P; Savić V; Roller A; Đorđić Crnogorac M; Stanojković T; Grgurić-Šipka S
J Inorg Biochem; 2020 Sep; 210():111164. PubMed ID: 32634653
[TBL] [Abstract][Full Text] [Related]
32. New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity.
Bratsos I; Simonin C; Zangrando E; Gianferrara T; Bergamo A; Alessio E
Dalton Trans; 2011 Oct; 40(37):9533-43. PubMed ID: 21853191
[TBL] [Abstract][Full Text] [Related]
33. Half-sandwich Ru(η
Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
[TBL] [Abstract][Full Text] [Related]
34. Ru(II)-Arene Complexes of Curcumin and Bisdesmethoxycurcumin Metabolites.
Pagliaricci N; Pettinari R; Marchetti F; Tombesi A; Pagliaricci S; Cuccioloni M; Galindo A; Fadaei-Tirani F; Hadiji M; Dyson PJ
Inorg Chem; 2024 Apr; 63(17):7955-7965. PubMed ID: 38634659
[TBL] [Abstract][Full Text] [Related]
35. Ruthenium(ii) and palladium(ii) homo- and heterobimetallic complexes: synthesis, crystal structures, theoretical calculations and biological studies.
Askari B; Amiri Rudbari H; Micale N; Schirmeister T; Efferth T; Seo EJ; Bruno G; Schwickert K
Dalton Trans; 2019 Nov; 48(42):15869-15887. PubMed ID: 31620752
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, characterisation and biological activities of [(p-cym)RuX(pz4lut)]n+ and [{(p-cym)RuX}2(μ-pz4lut)]n+ (X = Cl, H2O and pz4lut = α,α,α',α'-tetra(pyrazol-1-yl)-2,6-lutidine).
Tripathy SK; Surada RK; Manne RK; Mobin SM; Santra MK; Patra S
Dalton Trans; 2013 Oct; 42(39):14081-91. PubMed ID: 23938874
[TBL] [Abstract][Full Text] [Related]
37. One-pot synthesis of symmetric and asymmetric p-quinone ligands and unprecedented substituent induced reactivity in their dinuclear ruthenium complexes.
Schweinfurth D; Das HS; Weisser F; Bubrin D; Sarkar B
Inorg Chem; 2011 Feb; 50(3):1150-9. PubMed ID: 21214266
[TBL] [Abstract][Full Text] [Related]
38. Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancer.
Franco Machado J; Machuqueiro M; Marques F; Robalo MP; Piedade MFM; Garcia MH; Correia JDG; Morais TS
Dalton Trans; 2020 May; 49(18):5974-5987. PubMed ID: 32314752
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, reactivity studies, structural aspects, and solution behavior of half sandwich ruthenium(II) N,N',N''-triarylguanidinate complexes.
Singh T; Kishan R; Nethaji M; Thirupathi N
Inorg Chem; 2012 Jan; 51(1):157-69. PubMed ID: 22148465
[TBL] [Abstract][Full Text] [Related]
40. Effect of cysteine thiols on the catalytic and anticancer activity of Ru(II) sulfonyl-ethylenediamine complexes.
Chen F; Romero-Canelón I; Habtemariam A; Song JI; Banerjee S; Clarkson GJ; Song L; Prokes I; Sadler PJ
Dalton Trans; 2022 Mar; 51(11):4447-4457. PubMed ID: 35226015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
